Table 1.
Sample characteristics.
| Stage-1 cohort (N = 4,137) | Stage-2 cohort(N = 1,409) | |||||
|---|---|---|---|---|---|---|
| Yale-Penn (N = 3,017) | SAGE (N = 1,120) | |||||
| AA (N = 1,686) | EA (N = 1,331) | AA (N = 295) | EA (N = 825) | AA (N = 606) | EA (N = 803) | |
| age-years, mean±SD | 41.7±8.3 | 38.8±10.1 | 40.5±7.4 | 39.8±9.5 | 41.7±10.4 | 39.2±12.3 |
| Female (%) | 707 (42) | 495 (37) | 126 (42) | 311 (38) | 193 (32) | 260 (32) |
| BMI < 19 (%) | 23 (1) | 26 (2) | 3 (1) | 17 (2) | 10 (2) | 13 (2) |
| BMI 19–24.9 (%) | 447 (27) | 439 (33) | 68 (23) | 307 (37) | 140 (23) | 280 (35) |
| BMI 25–29.9 (%) | 590 (35) | 494 (37) | 119 (40) | 316 (38) | 220 (36) | 303 (38) |
| BMI 30–34.9 (%) | 339 (20) | 246 (19) | 56 (19) | 121 (15) | 127 (21) | 131 (16) |
| BMI > 35 (%) | 287 (17) | 126 (9) | 49 (17) | 64 (8) | 109 (18) | 76 (9) |